ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colonic Cancer
Colorectal Cancer
Rectal Cancer
Non-Small-Cell Lung Carcinoma
Pancreatic Cancer
Neoplasm Metastasis
Cancer

Colon Cancer trials near Phoenix, AZ, USA:

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

To learn if cemiplimab can help to control dMMR colon cancer....

Active, not recruiting
Colon Cancer
Drug: Cemiplimab

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Gilbert, Arizona, United States and 4 other locations

with histologically or cytologically confirmed stage IV colorectal cancer coming form three different patient populations:* Cohort 1a: 6 pat...

Active, not recruiting
Stage IV Rectal Cancer
Metastatic Colorectal Cancer
Drug: ATP128
Drug: BI 754091

Phase 1

Amal Therapeutics

Scottsdale, Arizona, United States and 11 other locations

This study will investigate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 in participants with advanced or...

Enrolling
Colorectal Cancer (CRC)
Colon Cancer
Biological: CBI-1214

Phase 1

Cartography Biosciences

Phoenix, Arizona, United States and 9 other locations

and pembrolizumab) given together for the treatment of colorectal cancer that:* is metastatic (spread to other parts of the body);* has the ...

Active, not recruiting
Metastatic Colorectal Cancer
Biological: Pembrolizumab
Biological: Cetuximab

Phase 2

Pfizer
Pfizer

Phoenix, Arizona, United States and 61 other locations

dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...

Active, not recruiting
Any Solid Tumor
Glioma
Drug: LY3410738
Drug: Gemcitabine

Phase 1

Lilly
Lilly

Phoenix, Arizona, United States and 32 other locations

This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...

Active, not recruiting
Any Solid Tumor
Colon Cancer
Drug: LOXO-292

Phase 1, Phase 2

Lilly
Lilly

Scottsdale, Arizona, United States and 85 other locations

The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with re...

Enrolling
Clear Cell Renal Cell Carcinoma
Biological: XmAb819

Phase 1

Xencor
Xencor

Phoenix, Arizona, United States and 26 other locations

This is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor...

Enrolling
Hormone Refractory Prostate Cancer
HR+ Breast Cancer
Drug: SHY-ONC6

Phase 1

SHY Therapeutics

Scottsdale, Arizona, United States and 3 other locations

or combinations in locally advanced, incurable, or metastatic solid tumors and/or oligometastatic malignancy and/or a high risk of recurrenc...

Enrolling
Solid Tumor
Colon Cancer
Drug: Fam-Trastuzumab Deruxtecan-Nxki
Drug: TTX-MC138

Phase 1, Phase 2

QuantumLeap Healthcare Collaborative

Phoenix, Arizona, United States and 9 other locations

This is a study to evaluate the safety and potential anti-tumor activity of an investigational agent called ARV-806 in Adults with Advanced ...

Active, not recruiting
Advanced Solid Cancer
KRAS G12D Mutation
Drug: ARV-806

Phase 1, Phase 2

Arvinas
Arvinas

Phoenix, Arizona, United States and 13 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems